skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 124  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: New Records: New From Last Week remove New Records: New From Last Month remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
147 A practical risk score for prediction of 6-month mortality in patients with acute heart failure: CHAM2P2
Material Type:
Article
Add to My Research

147 A practical risk score for prediction of 6-month mortality in patients with acute heart failure: CHAM2P2

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.156-158 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.145

Digital Resources/Online E-Resources

2
Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry
Material Type:
Article
Add to My Research

Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry

PloS one, 2024-05, Vol.19 (5), p.e0303348-e0303348 [Peer Reviewed Journal]

Copyright: © 2024 Lindberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0303348 ;PMID: 38787867

Full text available

3
168 Can the use of a structured management approach using abcdef mnemonic to manage multi-morbidity in HFpEF improve clinical outcomes?
Material Type:
Article
Add to My Research

168 Can the use of a structured management approach using abcdef mnemonic to manage multi-morbidity in HFpEF improve clinical outcomes?

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A178-A178 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.165

Digital Resources/Online E-Resources

4
Diaphragm thickness and mobility elicited by two different modalities of inspiratory muscle loading in heart failure participants: A randomized crossover study
Material Type:
Article
Add to My Research

Diaphragm thickness and mobility elicited by two different modalities of inspiratory muscle loading in heart failure participants: A randomized crossover study

PloS one, 2024-05, Vol.19 (5), p.e0302735-e0302735 [Peer Reviewed Journal]

Copyright: © 2024 Zacarias Rondinel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0302735 ;PMID: 38787839

Full text available

5
159 Diagnostic and prognostic significance of cancer antigen 125 in heart failure. A real-world analysis using a global federated database
Material Type:
Article
Add to My Research

159 Diagnostic and prognostic significance of cancer antigen 125 in heart failure. A real-world analysis using a global federated database

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A170-A171 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.156

Digital Resources/Online E-Resources

6
160 Pharmacotherapies in improving functional capacity in heart failure with preserved ejection fraction: a combined bayesian and frequentist network meta-analysis
Material Type:
Article
Add to My Research

160 Pharmacotherapies in improving functional capacity in heart failure with preserved ejection fraction: a combined bayesian and frequentist network meta-analysis

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.172-173 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.157

Digital Resources/Online E-Resources

7
157 Thirst alert: a randomised controlled trial and feasibility study of an electronic health record alert in patients with heart failure and fluid overload
Material Type:
Article
Add to My Research

157 Thirst alert: a randomised controlled trial and feasibility study of an electronic health record alert in patients with heart failure and fluid overload

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A168-A170 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.154

Digital Resources/Online E-Resources

8
164 The effect of beta-blockers on heart failure with preserved ejection fraction: a systematic review
Material Type:
Article
Add to My Research

164 The effect of beta-blockers on heart failure with preserved ejection fraction: a systematic review

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A175-A176 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.161

Digital Resources/Online E-Resources

9
156 Are current cut-offs to identify stage b heart failure (SBHF) appropriate in the UK?
Material Type:
Article
Add to My Research

156 Are current cut-offs to identify stage b heart failure (SBHF) appropriate in the UK?

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A167-A168 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.153

Digital Resources/Online E-Resources

10
174 An audit on the management of de novo diagnosis of hfref in the patients presenting with MI in a tertiary centre coronary care unit in the United Kingdom in accord with the European society of cardiology guidelines
Material Type:
Article
Add to My Research

174 An audit on the management of de novo diagnosis of hfref in the patients presenting with MI in a tertiary centre coronary care unit in the United Kingdom in accord with the European society of cardiology guidelines

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A184-A185 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.171

Digital Resources/Online E-Resources

11
New perspectives in the diagnosis and treatment of heart failure with preserved ejection fraction (HFpEF)
Material Type:
Article
Add to My Research

New perspectives in the diagnosis and treatment of heart failure with preserved ejection fraction (HFpEF)

Revue médicale suisse, 2024-05, Vol.20 (875), p.1005-1009 [Peer Reviewed Journal]

ISSN: 1660-9379 ;DOI: 10.53738/REVMED.2024.20.875.1005 ;PMID: 38783669

Full text available

12
The Role of Inflammasomes in Heart Failure
Material Type:
Article
Add to My Research

The Role of Inflammasomes in Heart Failure

International journal of molecular sciences, 2024-05, Vol.25 (10), p.5372 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms25105372 ;PMID: 38791409

Full text available

13
BS37 Investigation of the role of PMCA1 in heart failure with preserved ejection fraction
Material Type:
Article
Add to My Research

BS37 Investigation of the role of PMCA1 in heart failure with preserved ejection fraction

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A271-A272 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.263

Digital Resources/Online E-Resources

14
35 Percutaneous treatment of refractory heart failure secondary to early post-operative paraprosthetic aortic regurgitation
Material Type:
Article
Add to My Research

35 Percutaneous treatment of refractory heart failure secondary to early post-operative paraprosthetic aortic regurgitation

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A39-A39 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.35

Digital Resources/Online E-Resources

15
175 Quality improvement project: optimising care and fluid balance assesments in patients with heart failure
Material Type:
Article
Add to My Research

175 Quality improvement project: optimising care and fluid balance assesments in patients with heart failure

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A185-A186 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.172

Digital Resources/Online E-Resources

16
136 Genetic and phenotypic architecture of myocardial trabeculation in the left and right ventricles
Material Type:
Article
Add to My Research

136 Genetic and phenotypic architecture of myocardial trabeculation in the left and right ventricles

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A142-A143 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.134

Digital Resources/Online E-Resources

17
BS03 Interleukin-11: pro-inflammatory, profibrotic and cardiotoxic – a new therapeutic target in heart failure
Material Type:
Article
Add to My Research

BS03 Interleukin-11: pro-inflammatory, profibrotic and cardiotoxic – a new therapeutic target in heart failure

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.246-247 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.231

Digital Resources/Online E-Resources

18
162 advanced heart failure multi-disciplinary audit identifies patients who could benefit from transplantation & devices
Material Type:
Article
Add to My Research

162 advanced heart failure multi-disciplinary audit identifies patients who could benefit from transplantation & devices

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A174-A175 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.159

Digital Resources/Online E-Resources

19
155 Impact of SGLT2 inhibition on reverse cardiac remodeling in patients with heart failure: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

155 Impact of SGLT2 inhibition on reverse cardiac remodeling in patients with heart failure: a systematic review and meta-analysis

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A165-A167 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.152

Digital Resources/Online E-Resources

20
167 Impact of early introduction and uptitration of evidence-based heart failure medications on one-year mortality rates
Material Type:
Article
Add to My Research

167 Impact of early introduction and uptitration of evidence-based heart failure medications on one-year mortality rates

Heart (British Cardiac Society), 2024-06, Vol.110 (Suppl 3), p.A178-A178 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-BCS.164

Digital Resources/Online E-Resources

Results 1 - 20 of 124  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Resource Type 

  1. Articles  (107)
  2. Web Resources  (12)
  3. Reports  (5)
  4. More options open sub menu

Language 

  1. English  (119)
  2. Russian  (1)
  3. Chinese  (1)
  4. French  (1)
  5. Spanish  (1)
  6. Korean  (1)
  7. More options open sub menu

Searching Remote Databases, Please Wait